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1.Introduction
The gut mucosal immune system is a major site of defence 
against potential pathogenic organisms that gain entry into 
the human body via the gastrointestinal tract (GIT). By its 
very nature, the GIT is full of microbes, their antigens and 
potential antigens released by the chemical breakdown of 
food. The mucosal immune system of the gut, in response 
to this microbe and food-antigen-rich environment has 
developed sophisticated mechanisms by which it can 
selectively taste luminal contents and respond to these 
signals; either by initiation of an immune inflammatory 
response or by a homeostatic mechanism resulting in 
tolerance or non-responsiveness of the immune system, 
whereby we tolerate useful products in the gut. This 
mechanism is referred to as oral tolerance, allowing the 
host to gain benefit from food/nutrients and beneficial 
commensal organisms.
These commensal microbes present in the gut afford health 
benefits through a variety of ways which include provision 
of metabolites which regulate host nutrition, epithelial 
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Abstract
Gut mucosal macrophages play a pivotal role in driving mucosal immune responses, resulting in either activation of 
inflammatory immune responses to pathogenic challenge or tolerance to beneficial luminal contents such as food 
and commensal bacteria. Macrophage responses elicited are dependent on tissue environment and the resulting 
cell subset, where homeostatic macrophages resemble the M2 macrophage subset and inflammatory macrophages 
resemble M1s. Probiotics can modulate macrophage function with outcome dependent on subset present. Using 
a THP-1 monocyte cell line-derived model of CD14high/low M1 and M2 macrophages, the aim of this study was to 
investigate the immunomodulatory effects of a panel of heat-killed probiotic bacteria and their secreted proteins 
on the subset-specific inflammatory marker profile of TNFα, IL-6 and NFκB. M1 and M2 cells were generated 
by differentiation of monocyte stable transfectants for high and low CD14 expression with phorbol 12-myristate 
13-acetate and vitamin D3, respectively, where the resulting CD14lo M2 and CD14hi M1s mimicked homeostatic and 
inflammatory mucosal macrophages. Subsets were stimulated by enteropathic lipopolysaccharides in the presence 
or absence of heat-killed (HK) or secreted proteins (SP) from a panel of probiotic bacteria. Regulation of cytokine 
expression was measured by ELISA and NFκB activity by reporter assay. HK probiotics suppress CD14lo and augment 
CD14hi M1 and M2 production of TNFα whereas SPs augmented CD14hi M1 TNFα and were generally suppressive 
in the other subtypes. M2 macrophage IL-6 production was suppressed by both HK and SPs and differentially 
regulated in CD14lo and CD14hi M1s. NFκB activation failed to parallel the regulatory profiles for TNFα and IL-6 
which is suggestive of probiotic bacteria exerting their regulatory effects on these cytokines in an NFκB-independent 
manner. In conclusion, HK and SP probiotics differentially regulate macrophage cytokines and NFκB activation in 
a subset-dependent manner and suggest a cautionary approach to probiotic treatment of mucosal inflammation.
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cell turnover and compete with pathogenic organisms for 
nutrient sources and binding sites on epithelial cells, thus 
preventing pathogenic invasion/infection. More recently, 
these organisms have been observed to modulate gut 
mucosal immune function which has been the focus of 
much intense investigation. In addition, the ‘topping-up’ of 
these ‘friendly’ bacteria by probiotics has been established 
to modulate immune function and confer health benefit to 
allergies, inflammatory pathologies and cancer.
Integral to modulation of gut mucosal responses are the 
macrophage cells present in the lamina propria of the 
mucosal layer. Gut mucosal macrophages are generally 
hyporesponsive or tolerised in the homeostatic healthy 
functioning gut: hyporesponsive to nutrients, food antigens 
and commensals whereas retaining the ability to be 
activated and elicit an inflammatory immune response upon 
pathogenic challenge. These macrophages are generally 
representative of the M2 macrophage subset, they express 
scavenger receptors (mannose receptor MR, CD13, CD36), 
anti-inflammatory/regulatory cytokines (interleukin (IL)-
10 and transforming growth factor, TGFβ) and exhibit a 
reduced responsiveness to pathogen associated molecular 
patterns (PAMPs), i.e. macrophages fail to express CD14 
and selected Toll-like receptors (TLRs); but in addition, the 
expression of the co-stimulatory molecules CD80/CD86 
and the IgA FcR, CD89 are also reduced. These CD14lo 
M2-like macrophages, when in homeostatic conditions, are 
predominantly regulatory/anti-inflammatory and display a 
phagocytic phenotype characterised by the high expression 
of scavenger receptors (Platt and Mowat, 2008; Smith et 
al., 2001; Smythies et al., 2005). Macrophage effector 
phenotype, however, is partially governed by the local 
environment. Thus, in an inflammatory environment, gut 
mucosal macrophages exhibit a pro-inflammatory M1-like 
macrophage subset effector phanotype, characterised by the 
predominance of pro-inflammatory cytokine production, 
expression of high levels of CD14 (CD14hi) and expression 
of co-stimulatory molecules CD80 and CD86 (Segura et al., 
2002; Zareie et al., 2001). It is not clear, however, whether 
these different macrophage effector phenotypes result as a 
consequence of plasticity of one subset of gut macrophage 
cell or by recruitment and activation of a defined monocyte/
macrophage subset from the peripheral circulation.
Probiotic bacteria are immunomodulatory and can exert 
their effects on a wide array of immune and mucosal 
cells including T-cells, B-cells, natural killer (NK) cells 
(Takeda et al., 2006), dendritic cells (Foligne et al., 2007a), 
monocytes/macrophages and epithelial cells (Zhang et 
al., 2005). Dependent on cell type and strain of probiotic 
bacteria used, these immunomodulatory effects can 
manifest themselves as immune activatory, deviatory or 
regulatory/suppressive. Considering relative abundance 
and functionality in the gut mucosa, the potential role of 
probiotics in modulating macrophage function has been 
relatively sparsely investigated. Lactic acid bacteria (LAB), 
such as Lactobacillus rhamnosus, have been documented 
to modulate macrophage function by both suppressing and 
enhancing IL-12 production (Foligne et al., 2007b; Ichikawa 
et al., 2007; Shida et al., 2006), which will impact on Th1 
development and activation, hence cell mediated immunity 
to intracellular resident pathogens. These LAB have also 
been described to suppress mucosal tumour necrosis factor 
(TNFα) during inflammation (Borruel et al., 2002) and to 
augment the anti-inflammatory cytokine, IL-10 (Foligne et 
al., 2007b). In addition, the secreted protein extract from 
Lactobacillus plantarum inhibits NFκB activity (Petrof et 
al., 2009); such observations have suggested a suppressive 
role for L. plantarum and other probiotic bacterial species 
on NFκB-dependent inflammatory cytokines such as IL-
1γ, IL-6, IL-8, monocyte chemotactic peptide-1 (MCP-
1), IL-12 and TNFα. Thus, probiotic bacteria have been 
demonstrated to exert their immunomodulatory effects 
through both bacterial cell-associated mechanisms and 
through soluble secreted proteins (Frick et al., 2007; 
Sanchez et al., 2009; Yan et al., 2007) and metabolites such 
as short chain fatty acids (Foey, 2011).
These probiotic bacteria share common molecules (or 
pathogen associated molecular patterns, PAMPs) with 
pathogenic bacteria, which are recognised by pattern 
recognition receptors (PRRs) expressed by cells of the gut 
mucosa. Just how the immune system recognises beneficial 
commensal or probiotic microbes from pathogens is a subject 
of intense research efforts. One potential way by which the 
host differentiates between good and bad has been suggested 
to be mediated by the PRR, nucleotide oligomerisation 
domain-2 (NOD2); indeed several probiotic LAB strains 
have been shown to be recognised by this receptor 
(Hasegawa et al., 2006). NOD2 is an intracellular receptor 
which recognises muramyl dipeptide moieties derived 
from peptidoglycan (Girardin et al., 2003); the location 
of this receptor suggests that either the whole probiotic 
bacterium or parts of, are required to gain entry inside the 
cell by means of phagocytosis. This in itself, is suggestive of 
phagocytically competent cells such as the M2 macrophage 
subset and the potential role of scavenger receptors which 
predominate on the same cell type. Such a mechanism 
may be important in macrophage discrimination between 
commensals and pathogens, preventing inappropriate 
recognition of commensal PAMPs by their PRRs and the 
ensuing destructive inflammatory immune responses; thus 
mediating tolerance vs. immune activation decisions. Indeed, 
probiotic bacteria have been demonstrated to modulate 
phagocytosis; whereby being stimulatory to phagocytosis 
in healthy subjects and conversely, suppressive in allergic 
patients (Isolauri et al., 2001). Thus, recognition of PAMPs 
by PRRs such as TLRs and NODs, the phagocytic capability 
and functional phenotype of the macrophage determine 
responsiveness to probiotics as immuno-suppressive, 
regulatory or inflammatory.
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Gut mucosal macrophages have been characterised as 
CD14lo/absent, TLRlo/absent M2-like phenotype in healthy 
mucosa whereas CD14hi, TLRhi M1-like phenotype in 
inflammatory mucosa (Smith et al., 2001; Smythies et al., 
2005; Zareie et al., 2001). Thus, CD14 has been suggested 
as an indicator molecule of tolerogenic or inflammatory 
mucosal macrophages. CD14 is a multifunctional receptor; it 
facilitates innate responses to infectious non-self molecules 
as well as interacting with apoptotic self molecules, serving 
as a scavenger for apoptotic cells. It has been described to 
recognise the bacterial PAMPs; lipopolysaccharide (LPS), 
peptidoglycan, mycobacterial lipoarabinomannan and 
streptococcal cell wall polysaccharides (Pugin et al., 1994; 
Soell et al., 1995; Weidemann et al., 1997; Wright et al., 
1990), thus having the capability to recognise and bind 
components of both Gram negative and Gram positive 
bacteria and serving as a co-receptor for TLR2 and TLR4, 
hence driving inflammatory immune responses directed at 
non-self bacterial components. On the other hand however, 
CD14 has been demonstrated to recognise apoptotic 
cells for clearance by phagocytosis (Devitt et al., 1998; 
Pradhan et al., 1997). Such a clearance mechanism results 
in a regulatory, anti-inflammatory response (Fadok et al., 
1998). Probiotic modulation of these functionally distinct 
macrophage subsets present in the gut mucosa will be 
determined by CD14 expression and the receptors that it 
associates with, and the downstream effector signalling 
pathways.
The signal pathway transcription factor, NFκB plays a 
dominant role in inflammatory responses. It has been 
well established to regulate macrophage inflammatory 
cytokine production such as TNFα, IL-6, IL-8 and IL-1β 
(Bondeson et al., 1999). In addition, the role of NFκB in 
regulating macrophage phenotype has been investigated 
where inhibition of NFκB by adenovirus overexpression 
of the inhibitor, IκB, changed macrophage phenotype to a 
dominant anti-inflammatory phenotype (Wilson et al., 2005). 
This was extended, whereby an anti-inflammatory role was 
described for IKKβ by the inhibition of classical, M1-like 
macrophage responses (Fong et al., 2008). Surprisingly, the 
long term inhibition of IKKβ rendered mice more susceptible 
to IL-1β-associated endotoxin-induced shock. Inhibition 
of IKKβ, hence NFκB activation and NFκB-dependent 
inhibition of caspase-1 resulted in augmentation of IL-1β, 
demonstrating NFκB to play a negative regulatory role in 
IL-1β secretion (Greten et al., 2007). Thus, it is likely that 
macrophage phenotype, hence inflammatory phenotype, 
is integrally associated with NFκB subunit association and 
activation. Several studies have suggested that probiotics 
(both bacterial cell-associated and bacterial-free fractions) 
modulate NFκB activation, whereby VSL#3 suppressed 
NFκB activation in intestinal epithelial cells (Petrof et al., 
2004, 2009) and the same cells in a murine model of colitis 
(Marteau et al., 2004). It remains to be investigated whether 
probiotic modulation of distinct macrophage subsets and 
their effector cytokines is mediated through manipulation 
of NFκB-dependent mechanisms.
Current understanding of probiotic modulation of 
macrophage-mediated immune responses of distinct 
effector subsets relevant to mucosal homeostatic and 
inflammatory pathological environments is relatively poorly 
understood. Probiotic modulation of macrophage effector 
cytokines is, at best, confusing and often contradictory; 
observations being determined by cell source, level of 
differentiation, bacterial strain, bacterial preparation, 
stimulus used and local environment. Using a stably 
transfected NFκB-reporter cell line model of CD14lo/
CD14hi mucosal resident homeostatic- and infiltrating 
inflammatory-macrophages, the aim of this study was to 
investigate the relationship between a range of potentially 
immunoregulatory panel of probiotics (both bacterial cell 
and secreted protein preparations) and their effects on 
macrophage subset NFκB activation and corresponding 
cytokine effector phenotype, of relevance to mucosal 
macrophages found in the gastrointestinal tract.
2. Materials and methods
Bacterial culture and preparation of heat-killed and 
secreted protein extracts
Bifidobacterium breve strain NCIMB 8807 (BB), L. 
rhamnosus GG strain NCIMB 8824 (LR), Lactobacillus 
salivarius strain NCIMB 41606 (LS) and L. plantarum 
strain NCIMB 41605 (LP) were obtained from NCIMB 
(Aberdeen, UK). Lactobacillus fermentum strain MS15 
(LF) was isolated from the crop of a chicken (Savvidou, 
2009) and obtained from internal microbiology stocks at 
the University of Plymouth (UK). These probiotic bacterial 
species were cultured aerobically in De Man Rogosa Sharp 
(MRS) broth at 37 °C for 18 hours until stationary phase was 
achieved. Bacterial cells were harvested according to the 
method described in Habil et al. (2011). In brief, bacterial 
cells were harvested and washed in phosphate buffered 
saline and viable counts adjusted to a density of 1×109 
cfu/ml. Probiotic bacteria were adjusted to 1×1010 cfu/ml 
and heat killed for 2 hours at 90 °C (HK) according to the 
protocol of Young et al. (2004). Cell death was confirmed by 
plating on MRS agar and incubation for a minimum of 18 
hours. In addition, secreted protein (SP) was extracted by 
trichloroacetic acid precipitation of proteins secreted into 
growth supernatant according to the protocol of Sanchez et 
al. (2009). Protein content was verified by SDS-PAGE and 
quantified by calibration to Bradford protein assay. Secreted 
protein was adjusted to a stock concentration of 1 mg/ml.
Monocyte and macrophage culture
Transfectant human monocytic THP-1 NFκB reporter 
cell lines, THP-1Blue (CD14lo) and THP-1Blue-CD14 
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(CD14hi) (Autogen Bioclear, Calne, UK) were routinely 
used for this study between passages 7 and 25 and 
maintained in R10 medium composed of RPMI-1640 
medium supplemented with 10% (v/v) foetal calf serum, 
2 mM L-glutamine and 100 U/ml penicillin or 100 μg/ml 
streptomycin (Lonza, Wokingham, UK) in the presence of 
the selection antibiotics, 200 μg/ml zeocin or 200 μg/ml 
zeocin and 10 μg/ml blastocidin, respectively. Cells were 
plated out at 1×105 cells/100 μl/well in R10 medium in 96 
flat-bottomed well tissue culture plates. Pro-inflammatory 
(M1-like) macrophages and anti-inflammatory (M2-like) 
macrophages were generated by differentiation of these 
monocytes in the presence of 25 ng/ml phorbol 12-myristate 
13-acetate for 3 days or 10 nM 1,25-(OH)2-vitamin D3 
(Sigma-Aldrich, Poole, UK), for 7 days, respectively 
(Daignealt et al., 2010). The resulting CD14lo M2 and 
CD14hi M1 macrophage subsets were representative of 
homeostatic and inflammatory pathological mucosal 
macrophages, respectively. In addition, CD14lo M1 and 
CD14hi M2 subsets were also studied, acting as internal 
controls for observations of CD14 expression responses 
of the inflammatory pathological and homeostatic 
macrophages, and as potential intermediate subsets 
dependent on whether the macrophage subset is derived 
from recruited CD14hi/CD14lo peripheral blood monocytes 
or as a consequence of environmental modification of 
resident mucosal macrophages.
Activation of macrophage cytokine production
Macrophages were stimulated by the bacterial PAMP; 
100 ng/ml Escherichia coli strain K12 LPS (expressed in 
enteropathic Gram negative bacteria and detected by TLR4) 
and cultured for 18 hours (determined as optimal time 
period for secretion of the cytokines TNFα and IL-6) in 
a humidified environment at 37 °C, 5% CO2, after which 
time supernatants were harvested and stored at -20 °C until 
required for assay by sandwich ELISA.
Regulatory effect of heat-killed and secreted protein 
probiotic preparations
To investigate probiotic regulation of macrophage cytokine 
production and NFκB activation, HK- and SP-probiotics 
were added in culture to final concentrations of 3×108 
bacterial cells/ml and 3 μg/ml, respectively, as a pre-
treatment for 18 hours prior to K12-LPS stimulation (100 
ng/ml) for a further 18 hours in a humidified environment 
at 37 °C, 5% CO2. To demonstrate a physiologically-relevant 
role for HK- and SP-probiotics, cytotoxicity assays (MTT 
and trypan blue exclusion) were carried out on both 
macrophages, up to 109 cells/ml and 100 μg/ml, respectively. 
No significant reductions in viability were observed for the 
concentrations used; viability was routinely >90%.
Cytokine measurement
Macrophage production of the inflammatory cytokines, 
TNFα and IL-6, were analysed by sandwich ELISA using 
commercially available capture and detection antibodies 
from BD-Pharmingen (Oxford, UK). Due to supernatant 
volume constraints, the CD14hi and CD14lo NFκB reporter 
transfectants were assayed for the pro-inflammatory 
cytokine, TNFα, and the dual pro- and anti-inflammatory 
cytokine, IL-6, and NFκB activity (see next paragraph). 
Protocols were followed according to manufacturer’s 
instructions and compared to standard curves, using 
the recognised international standards available from 
NIBSC (Potter’s Bar, UK). Colorimetric development was 
measured spectrophotometrically by an OPTIMax tuneable 
microplate reader at 450 nm and analysed by Softmax Pro 
version 2.4.1 software (Molecular Devices Corp., Sunnyvale, 
CA, USA).
NFκB activity measurement
NFκB activity was measured by colorimetric reporter 
gene assay for secreted embryonic alkaline phosphatise 
(SEAP) associated with the stably-transfected reporter 
gene cell lines, THP-1Blue (CD14lo) and THP-1Blue-
CD14 (CD14hi) (Autogen Bioclear). Briefly, at conclusion 
of the experiment, fresh supernatant was harvested and 
incubated with Quantiblue colorimetric reagent (Autogen 
Bioclear) for 30 minutes at 37 °C, 5% CO2. Colorimetric 
development was measured by an OPTIMax tuneable 
microplate reader at 620 nm and analysed by Softmax Pro 
version 2.4.1 software (Molecular Devices Corp.). Colour 
development was directly proportional to the reporter gene 
SEAP expression and NFκB activity.
Statistical analysis
Data were analysed using balanced analysis of variance 
(General Linear Model, Minitab version 16) followed by a 
multiple comparison test (LSD, least significant difference 
test). All means are presented with the appropriate standard 
error. Significance was set at the confidence intervals of 
0.05, 0.01 and 0.005.
3. Results
Secreted protein and heat-killed probiotic strains 
selectively modulate macrophage subset TNFα production
Mucosal macrophage effector phenotype and functions 
differ from other tissue macrophages. They are generally 
hyporesponsive CD14lo when present in homeostatic, 
tolerogenic mucosa whereas under inflammatory conditions 
they are CD14hi and express inflammatory mediators. 
In an attempt to extrapolate earlier data to gut mucosal 
macrophages in inflammatory or tolerogenic conditions, 
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CD14hi and CD14lo stable transfectants were driven towards 
M1 and M2 macrophage subsets and stimulated by K12-LPS 
in the presence or absence of heat-killed or secreted protein 
preparations from a range of probiotic bacterial species.
Probiotic bacteria have been demonstrated to modulate 
innate immunity. This experiment was undertaken to 
establish whether heat-killed (in the absence of any non-
specific effects of lactic acid produced) or secreted protein 
from a panel of established probiotic bacteria exerted 
immunomodulatory effects on the expression of the pro-
inflammatory cytokine, TNFα, by THP-1-derived M1-
like and M2-like macrophage subsets. Results indicated 
that HK- and SP-probiotic bacteria samples differentially 
regulated LPS-induced TNFα production by M1 and M2 
macrophage subsets; modulation of TNFα being dependent 
on macrophage subset, CD14 expression and probiotic 
strain. The most obvious effect was observed for CD14hi 
macrophages, where in CD14hi M1s (representative of 
inflammatory infiltrating macrophages) heat killed 
probiotics augmented LPS-induced TNFα by ×4, ×3.2, 
×3.6, ×4 and ×3.7 of control (1,161±148 pg/ml) and secreted 
proteins augmented by ×4, ×4.1, ×4.1, ×3 and ×3.5 for BB, 
LR, LF, LS and LP, respectively (Figure 1B). CD14hi M2s 
displayed a differential sensitivity to HK compared to SP 
(Figure 1D). HK obtained for the LABs all augmented TNFα 
production (control 14±1 pg/ml) resulting in levels ×4.9, 
×12, ×3.6 and ×7 for LR, LF, LS and LP, respectively. SP 
extracts, in comparison, only weakly modulated cytokine 
production where LS suppressed production by 36% 
(control 14±1 pg/ml to 9±1 pg/ml) and LP augmented by 
86% (control 14±1 pg/ml to 26±3 pg/ml). Generally, in the 
case of CD14lo macrophages, HK and SP probiotics partially 
suppressed LPS-induced TNFα production. In the case of 
CD14lo M1s, HK suppressed cytokine production (control 
levels of 1,454±94 pg/ml) by 51% (709±4 pg/ml), 19% 
(1,184±98 pg/ml), 40% (876±175 pg/ml) and 57% (628±316 
pg/ml) for BB, LF, LS and LP, respectively. SP suppressed 
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Figure 1. Secreted protein and heat-killed probiotic strains selectively modulate macrophage subset TNFα production. THP-1-derived 
CD14hi and CD14lo macrophage subsets were stimulated with 100 ng/ml Escherichia coli K12 lipopolysaccharides in the presence 
or absence of 3×108 cfu/ml heat-killed (HK) probiotic bacterial strains (Bifidobacterium breve (BB), Lactobacillus rhamnosus (LR), 
Lactobacillus fermentum (LF), Lactobacillus salivarius (LS) and Lactobacillus plantarum (LP)), depicted by clear bars, or 3 μg/ml 
secreted protein extracted from each of these probiotic strains (depicted by hatched bars). M1 and M2 macrophages were generated 
by differentiating CD14hi and CD14lo THP-1- NFκB reporter monocytes with either 25 ng/ml phorbol 12-myristate 13-acetate for 
3 days or 10 nM 1,25-(OH)2 vitamin D3 for 7 days, respectively. TNFα pro-inflammatory cytokine production is expressed as the 
mean±SD in pg/ml for (A) CD14loM1, (B) CD14hi M1, (C) CD14lo M2, and (D) CD14hi M2 macrophage-like subsets. Data displayed 
is a representative experiment with triplicate samples of n=4 replicate experiments. Significant effects compared to stimulus 
control for the indicated macrophage subset are indicated as * P<0.05, ** P<0.01 and *** P<0.005.
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by 47% (770±120 pg/ml), 59% (590± 6 pg/ml) and 52% 
(704±119 pg/ml) for LR, LF and LP. (Figure 1A). Finally, 
in the case of CD14lo M2 macrophages (representative 
of homeostatic healthy gut mucosal macrophages), HK 
suppressed TNFα (control 21±2 pg/ml) by 62%, 38%, 33%, 
57% and 52% for BB, LR, LF, LS and LP. SP suppressed by 
19%, 62%, 24% and 67% for BB, LF, LS and LP, respectively, 
whereas LR-SP augmented TNFα by 38% (Figure 1C).
Secreted protein and heat-killed probiotic strains 
selectively modulate macrophage subset IL-6 production
The data above clearly demonstrates an immunomodulatory 
role for both HK and SP probiotics with respect to the 
expression of the pro-inflammatory cytokine TNFα by 
pro-inflammatory (M1) and anti-inflammatory/regulatory 
(M2) macrophage subsets. These macrophage subsets 
have been described to express different cytokine profiles 
which underlie their effector function; one such differential 
cytokine which exhibits both pro-inflammatory and anti-
inflammatory properties is IL-6. This experiment was 
undertaken to establish whether HK and SP probiotics 
exerted any selective immunomodulatory effects on the 
expression of IL-6 by M1 and M2 macrophage subsets. 
Results indicated that HK and SP differentially regulated 
IL-6 cytokine expression by M1 and M2 macrophage 
subsets. Both HK and SP preparations suppressed LPS-
induced IL-6 production by M2 macrophages, potency 
of suppression being regulated by the level of CD14 
expression. With respect to CD14lo M2 macrophages 
(representative of homeostatic healthy gut mucosal 
macrophages), HK suppressed IL-6 (control 547±52 
pg/ml) by 58%, 58%, 34%, 98% and 91% for BB, LR, LF, 
LS and LP. SP suppressed by 86%, 19%, 73%, 94% and 
92% for BB, LR, LF, LS and LP, respectively (Figure 2C). 
IL-6 production by CD14hi M2s was highly sensitive to 
suppression, where HK suppressed cytokine production 
(control 1,681±144 pg/ml) by 98%, 96%, 95%, 99% and 
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Figure 2. Secreted protein and heat-killed probiotic strains selectively modulate macrophage subset IL-6 production. THP-1-derived 
CD14hi and CD14lo macrophage subsets were stimulated with 100 ng/ml Escherichia coli K12 lipopolysaccharides in the presence 
or absence of 3×108 cfu/ml heat-killed (HK) probiotic bacterial strains (Bifidobacterium breve (BB), Lactobacillus rhamnosus 
(LR), Lactobacillus fermentum (LF), Lactobacillus salivarius (LS) and Lactobacillus plantarum (LP)), depicted by clear bars, or 
3 μg/ml secreted protein extracted from each of these probiotic strains (depicted by hatched bars). M1 and M2 macrophages 
were generated by differentiating CD14hi and CD14lo THP-1-NFκB reporter monocytes with either 25 ng/ml phorbol 12-myristate 
13-acetate for 3 days or 10 nM 1,25-(OH)2 vitamin D3 for 7 days, respectively. The production of the inflammatory mediator IL-6 is 
expressed as the mean±SD in pg/ml for (A) CD14loM1, (B) CD14hi M1, (C) CD14lo M2 and (D) CD14hi M2 macrophage-like subsets. 
Data displayed is a representative experiment with triplicate samples of n=4 replicate experiments. Significant effects compared 
to stimulus control for the indicated macrophage subset are indicated as * P<0.05, ** P<0.01 and *** P<0.005.
 Probiotic modulation of macrophage subset effector responses
Beneficial Microbes 2(4) 289
98% and SP suppressed by 95%, 95%, 93%, 96% and 95% 
for BB, LR, LF, LS and LP, respectively (Figure 2D). Pro-
inflammatory M1 macrophages exhibit a different IL-6 
regulatory profile upon exposure to HK and SP probiotics. 
CD14lo M1 macrophages HK-BB, HK-LR, HK-LS and 
HK-LP augment LPS-induced IL-6 (control 216±5 pg/ml) 
by ×1.3, ×2.6, ×1.8 and ×2.1, respectively, whereas HK-LF 
suppressed IL-6 production by 29% (Figure 2A). LR-SP, LS-
SP and LP-SP suppressed IL-6 by 30%, 26% and 49%, LF-SP 
augmented cytokine production by ×1.4 and BB-SP failed 
to modulate LPS-induced IL-6 (Figure 2A). The CD14hi 
M1 subset (representative of infiltrating inflammatory 
mucosal macrophages) displayed an intriguing profile upon 
introduction of heat-killed or secreted protein of these 
probiotic strains. Heat-killed LF, LS and LP suppressed IL-6 
(LPS control 62±8 pg/ml) by 61%, 61% and 74%, whereas 
the secreted protein from the same strains augmented 
production by 55%, 26% and 11%, respectively. HK-LR. 
and LR-SP suppressed IL-6 by 17% and 11%. Finally, B. 
breve failed to modulate LPS-induced IL-6 in these pro-
inflammatory macrophages (Figure 2B).
Secreted protein and heat-killed probiotic strains 
selectively modulate macrophage subset NFκB activity
Both TNFα and IL-6 are regulated by NFκB and exhibit 
binding consensus sequences in their respective promoter 
regions. Any such regulation of the expression of these 
inflammatory cytokines by probiotic bacteria was expected 
to be as a consequence of modulation of NFκB activity. 
When comparing profiles between TNFα, IL-6 and NFκB, 
these data are suggestive that probiotic regulation of these 
pro-inflammatory cytokines is largely independent of NFκB 
activity. One clear observation was that the probiotic 
secreted protein augmented NFκB activation in CD14lo M1, 
CD14lo M2 and CD14hi M2 macrophages. SP only partially 
or failed to suppress NFκB activity upon LPS stimulation 
of CD14hi M1s (Figure 3B). SP augmented NFκB in CD14lo 
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Figure 3. Secreted protein and heat-killed probiotic strains selectively modulate macrophage subset NFκB activity. THP-1-derived 
CD14hi and CD14lo macrophage subsets were stimulated with 100 ng/ml Escherichia coli K12 lipopolysaccharides in the presence 
or absence of 3×108 cfu/ml heat-killed (HK) probiotic bacterial strains (Bifidobacterium breve (BB), Lactobacillus rhamnosus 
(LR), Lactobacillus fermentum (LF), Lactobacillus salivarius (LS) and Lactobacillus plantarum (LP)), depicted by clear bars or 3 
μg/ml secreted protein extracted from each of these probiotic strains (depicted by hatched bars). M1 and M2 macrophages were 
generated by differentiating CD14hi and CD14lo THP-1-NFκB reporter monocytes with either 25 ng/ml phorbol 12-myristate 13-acetate 
for 3 days or 10 nM 1,25-(OH)2 vitamin D3 for 7 days, respectively. NFκB reporter gene activity is expressed as the mean±SD in 
arbitrary absorbance units (A620nm) for (A) CD14
loM1, (B) CD14hi M1, (C) CD14lo M2 and (D) CD14hi M2 macrophage-like subsets. 
Data displayed is a representative experiment with triplicate samples of n=4 replicate experiments. Significant effects compared 
to stimulus control for the indicated macrophage subset are indicated as * P<0.05, ** P<0.01 and *** P<0.005.
N. Habil et al.
290 Beneficial Microbes 2(4)
M1s (LPS control level of 0.530±0.063 arbitrary units) by 
53%, 32%, 69%, 47% and 60% (Figure 3A); CD14lo M2s 
(LPS control 0.427±0.009 arbitrary units) by 92%, 116%, 
63%, 83% and 156% (Figure 3C) and CD14hi M2s (LPS 
control 0.363±0.005 arbitrary units) by 36%, 97%, 138%, 
58% and 144% for BB, LR, LF, LS and LP secreted protein 
extracts, respectively (Figure 3D). With the exception of 
LF-SP, where no modulation of NFκB was observed, the 
probiotic SPs only partially suppressed CD14hi M1 NFκB 
(LPS control 1.198±0.084 arbitrary units) by 13%, 23%, 30% 
and 20% for BB, LR, LS and LP, respectively (Figure 3B). The 
heat-killed preparations seemed to partially suppress M1 
NFκB activation whereas they augmented NFκB activation 
in the M2 macrophage subset. In both CD14lo M1 and 
CD14hi M1s, HK-BB failed to modulate NFκB activity. 
The HK-LABs suppressed NFΚB: where in CD14lo M1s, 
LPS-induced NFκB activity was suppressed by 42%, 25%, 
28% and 31% (Figure 3A) and in CD14hi M1s by 28%, 32%, 
96% and 28% for LR, LF, LS and LP, respectively (Figure 3B). 
HK-LABs generally augmented LPS-induced NFκB activity 
in M2 macrophages, whereas the heat-killed preparation 
of B. breve failed to modulate NFκB activity. HK-probiotics 
augmented NFκB activity in CD14hi M2s by 29%, 65%, 125% 
and 59% for LR, LF, LS and LP, respectively (Figure 3D). 
Finally, in the case of CD14lo M2s, HKs from LF, LS and 
LP weakly modulated NFκB activity, augmenting by 26%, 
20% and 33%, respectively (Figure 3C).
4. Discussion and conclusions
The probiotic bacterial stains (BB, LR, LF, LS and LP) 
differentially modulate macrophage production of 
the inflammatory mediator cytokines TNFα and IL-6. 
Immunomodulation of such macrophage-derived mediators 
is dependent on macrophage subset present in the mucosa, 
the CD14 expression and the format by which the probiotic 
is presented, i.e. bacterial cell wall associated (contact signal) 
or soluble secreted product (non contact-mediated signal).
Probiotic bacteria used in this study exhibited a strong pro-
inflammatory effect on CD14hi M1 macrophages which 
mimic infiltrating, inflammatory mucosal macrophages. Both 
heat-killed (HK)- and secreted protein (SP)-preparations 
augmented LPS-induced TNFα production in these 
macrophages. In general, CD14lo M1 macrophage TNFα 
was partially suppressed by these probiotic preparations with 
the exception of HK-LR, BB-SP and LS-SP which failed to 
modulate TNFα. These contrasting data between CD14hi and 
CD14lo M1s highlight an important role for CD14 expression 
in probiotic immunomodulation. M2 macrophages were 
relatively poor producers of TNFα. CD14lo M2 cells however, 
which mimic homeostatic mucosal macrophages, show a 
partial probiotic modulation; all HK-strains suppressed LPS-
induced TNFα, most SPs were suppressive apart from LR-
SP which up-regulated TNFα. With respect to CD14hi M2 
macrophage TNFα production, heat-killed LABs augmented 
LPS-induced TNFα whereas B. breve failed to modulate 
this cytokine. This modulatory activity would appear to 
be associated with the bacterial cell, as secreted protein 
failed to modulate pro-inflammatory TNFα in CD14hi M2 
cells. IL-6 production was differentially modulated by HK 
and SP probiotic preparations. HK-LF, HK-LS and HK-
LP suppressed CD14hi M1 macrophage IL-6 whereas the 
secreted protein from these three probiotics augmented 
IL-6. BB and LR failed to modulate this cytokine. CD14lo 
M1 macrophages produce a higher level of IL-6 compared 
to the CD14hi M1s. They also exhibit differential regulation 
by probiotics, in contrast to observations of modulation 
of CD14hi M1s; HK-LR, HK-LS and HK-LP augmented 
IL-6. M2 macrophages produce higher levels of IL-6 than 
M1s and both CD14hi and CD14lo M2 macrophage IL-6 
production was suppressed by both HK- and SP- probiotics 
used in this study. CD14hi M2 macrophages were extremely 
sensitive to probiotic suppression of LPS-induced IL-6. For 
the first time in this study, B. breve demonstrated a clear 
immunoregulatory capacity, where both SP and HK extracts 
suppressed IL-6 in both CD14hi and CD14lo M2s. Thus, 
probiotics differentially modulate the pro-inflammatory 
cytokines TNFα and IL-6 produced by LPS-stimulated M1 
and M2 macrophages.
LPS induction of monocyte/macrophage pro-inflammatory 
cytokine expression is well established to be NFκB 
-regulated (Bondeson et al., 1999). Indeed, both IL-6 and 
TNFα are regulated by NFκB and express NFκB binding 
consensus sequences in their promoter regions. It was 
expected that NFκB activation would parallel probiotic 
regulation of TNFα and IL-6. In fact, the only profile 
that partially parallels NFκB activation is the regulation 
of IL-6 production by CD14hi M1s. M2 macrophage 
NFκB activation is partially augmented by these probiotic 
bacteria. Regulation of IL-6 however, resulted in the 
opposite effect, suppression, suggesting that probiotic 
modulation of IL-6 was NFκB -independent. In addition, 
probiotic augmentation of TNFα by pro-inflammatory 
CD14hi M1 macrophages was also NFκB -independent, 
as NFκB was either partially suppressed or unaltered. 
Modulation of CD14hi M2 TNFα did, however, parallel 
that of NFκB activation. Due to this poor level of association 
of NFκB with cytokine production, it is likely that other 
signalling pathways are involved in probiotic regulation. 
LPS activates mitogen activated protein kinases (MAPKs) 
(Foey et al., 1998). These pathways are regulated by the 
probiotic bacterium Lactobacillus reuteri which suppressed 
macrophage TNFα production through the inhibition 
of the transcription factor, AP-1 (Lin et al., 2008). AP-1 
inhibition is suggestive that this probiotic may effect 
its regulation by suppression of the p38, p42/p44 ERK 
and JNK MAPKs. In addition to probiotics modulating 
MAPKs, cytokine production may be modulated directly 
via activation of other signal regulators or indirectly through 
the downstream activity of early-expressed cytokines. 
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Probiotics are generally Gram-positive bacteria that 
express peptidoglycan in their cell wall. Peptidoglycan is 
recognised by the intracellular receptor NOD2 (Hasegawa 
et al., 2006), which, through expression of short and long 
splice variants can positively or negatively regulate NFκB/
MAPK-dependent pro-inflammatory cytokines (Girardin et 
al., 2003; Rosentiel et al., 2006). Peptidoglycan also activates 
the transcription factors AP-1 and CREB/ATF in M2-like 
macrophages (Gupta et al., 1999). Several pro-inflammatory 
cytokine promotors possess CREB/ATF-binding sequences, 
indeed cAMP/CREB negatively regulates the pro-
inflammatory cytokine TNFα, whilst, at the same time, 
inducing the expression of the anti-inflammatory cytokine 
IL-10 (Foey et al., 2003). Thus, pro-inflammatory cytokines 
may be modulated indirectly by probiotic bacteria through 
the production of anti-inflammatory/regulatory cytokines. 
IL-10 may induce suppressor of cytokine signalling (SOCS) 
proteins, suppressing the activity and expression of several 
cytokines. One such example includes IFNγ, significant 
for activation and differentiation of pro-inflammatory M1 
macrophages. Interestingly, similar to IL-10 regulation, 
IL-6, when acting as an anti-inflammatory mediator, 
induces SOCS (Xing et al., 1998). This negative feedback 
mechanism may partially explain the differing probiotic 
regulation observed between IL-6 and TNFα production, 
in particular, for CD14hi M1 and M2 macrophages. 
Additionally, there is a reciprocal relationship between 
IL-6 and TNFα, in conditions where TNFα is augmented or 
highly expressed, IL-6 expression is low/suppressed. These 
regulatory processes suggest probiotic bacteria to modulate 
macrophage-driven responses by inducing endotoxin 
tolerance to PAMPs. In this study, tolerance may be initiated 
via chronic LPS stimulation or cross-tolerisation through 
NOD2, TLR2, TNF-R and IL-1βR signalling (Ferlito et al., 
2001; and reviewed in Biswas and Lopez-Collazo, 2009). 
This study suggests that regulation/tolerisation is likely 
to be dependent on environmental stimuli, macrophage 
lineage and CD14 expression. Future research will focus 
on the mechanisms of endotoxin tolerance, mediated 
by probiotics, facilitating a comprehensive mechanistic 
understanding of probiotic immunomodulatory function.
With respect to CD14 expression, CD14hi expression levels 
dramatically affected LPS-induced TNFα production, where 
the probiotic bacteria used generally augmented this pro-
inflammatory cytokine in both M1 and M2 macrophages; 
modulation was less pronounced in CD14lo macrophages. 
CD14 has been described to be both pro-inflammatory, 
through oligomerisation with the LPS receptor TLR4, 
and anti-inflammatory through its action as a scavenger 
receptor for apoptotic cells. The relative suppression of 
TNFα produced by CD14lo macrophages would suggest that 
modulation is as a consequence of down-regulation of the 
CD14/TLR4/TLR2 pro-inflammatory complex rather than 
downstream suppressive function of IL-10 or TGFβ induced 
by the recognition and phagocytosis of apoptotic cells. 
M2 IL-6 production was suppressed by probiotics with a 
stronger suppression evident in CD14hi M2s. Regarding the 
fact that IL-6 is both pro- and anti-inflammatory, probiotic 
suppression of this cytokine may exhibit inflammatory and 
tolerogenic/suppressive function. Modulation of M1 IL-6 
production was less clear and exhibited both suppressive 
and augmentation responses for both CD14hi and CD14lo 
which appeared to be strain selective and dependent 
on form of probiotic used to modulate the macrophage 
response.
Generally, the form of probiotic used (heat-killed or 
secreted protein) showed little difference in modulation 
of LPS-induced TNFα and IL-6. Two notable exceptions 
presented themselves for CD14hi M2 TNFα and CD14hi 
M1 IL-6 production: heat-killed LABs strongly augmented 
CD14hi M2 TNFα whereas secreted protein weakly 
modulated this cytokine. On the other hand, CD14hi M1 
IL-6 was suppressed by HK-preparations of L. fermentum, 
L. salivarius and L. plantarum whereas their secreted 
proteins partially augmented IL-6. Heat-killed probiotics 
utilised, investigated the immunomodulatory capability 
of cell-associated factors whereas secretory protein 
preparation investigated the potential for secreted, soluble 
immunomodulators. Preliminary SDS-PAGE analysis 
has identified several proteins either consistent between 
probiotic strains or strain-specific (data not shown). A 
previous investigation on L. rhamnosus GG conditioned 
medium identified several potential immunoregulators 
including a cell-wall-associated hydrolase, sepin B1 and a 
transcriptional regulator (Sanchez et al., 2009). Additionally, 
secreted immunomodulatory proteins have been suggested 
to modulate signalling pathways driving pro-inflammatory 
cytokine production and function (Frick et al., 2007; Yan et 
al., 2007). From this and other studies it can be concluded 
that beneficial immunomodulatory effects are associated 
with both bacterial cell-associated and secretable fractions, 
thus any future modulation of the immune system is best 
considering this, making use of both fractions provided 
by delivery of live probiotic strains either individually or 
in combination.
Cytokine production acts as a useful readout for probiotic 
immunomodulation. These bacteria are capable of both 
driving immune responses towards predominant Th1 
and Th2 responses and suppressing such responses. 
This suggests probiotics to manipulate and redress 
immunopathological mechanisms: Th1-driven pathologies 
such as CD, may benefit from probiotics that either 
suppress harmful immune reactions or induce type II 
cytokines (IL-10, IL-4, IL-13) and conversely, Th2-driven 
pathologies such as ulcerative colitis, may benefit from 
immunosuppressive probiotics or those that induce type I 
cytokine expression (IFNγ, IL-12 and TNFα). Combinations 
of probiotics will allow development of disease-group-
specific treatments (Th1 or Th2-driven) based on a thorough 
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understanding of the immunopathogenic mechanisms. 
In the context of mucosal macrophages, some probiotics 
may be inappropriate in inflammatory pathologies where 
CD14hi M1 subset cells predominate (Zareie et al., 2001) 
as, according to findings in this study, probiotic treatment 
may enhance inflammation by augmentation of TNFα 
production. A cautionary approach to their usage is 
recommended. On the other hand, probiotic treatment of 
CD14lo M2s, resembling homeostatic/regulatory mucosal 
macrophages (Platt and Mowat, 2008; Smith et al., 2001; 
Smythies et al., 2005), fails to augment inflammatory 
cytokines and may well induce expression of the regulatory 
cytokines, IL-10 and TGFβ, resulting in tolerance/immune 
hyporesponsiveness.
In conclusion, probiotic modulation of macrophage 
inflammatory cytokines TNFα and IL-6 is largely NFκB-
independent, but dependent on macrophage subset and 
the nature by which the probiotic is introduced. Probiotic 
strains used can differentially exert both immune activatory 
or suppressive functions. Future probiotic development will 
consider whether they are to be used prophylactically in 
healthy individuals or as a therapeutic treatment of defined 
pathological conditions, probiotic strain-specific effects, 
gut mucosal integrity and immune phenotype of mucosal 
macrophages – one step closer to personalised medicine!
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